Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a ...
Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by cost-cutting measures and ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab ... The Hesse-based company changed its outlook for its Healthcare business to "slight growth", compared ...
Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is ...
German companies including Merck and ZEISS expressed strong confidence and high hopes for the Chinese market at the China ...
Meanwhile, in the fertility space, where EMD Serono has a long-standing legacy, the company remains committed to support those who need help building their families. “In Canada, one in six couples has ...
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Intel Corporation, one of the world’s largest semiconductor designers and ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor ...
3 Estimate based on the data from 2022. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees ...